TY  - GEN
AU  - Toyoda,Hidenori
AU  - Atsukawa,Masanori
AU  - Takaguchi,Koichi
AU  - Senoh,Tomonori
AU  - Michitaka,Kojiro
AU  - Hiraoka,Atsushi
AU  - Fujioka,Shinichi
AU  - Kondo,Chisa
AU  - Okubo,Tomomi
AU  - Uojima,Haruki
AU  - Tada,Toshifumi
AU  - Yoneyama,Hirohito
AU  - Watanabe,Tsunamasa
AU  - Asano,Toru
AU  - Ishikawa,Toru
AU  - Tamai,Hideyuki
AU  - Abe,Hiroshi
AU  - Kato,Keizo
AU  - Tsuji,Kunihiko
AU  - Ogawa,Chikara
AU  - Shimada,Noritomo
AU  - Iio,Etsuko
AU  - Deguchi,Akihiro
AU  - Itobayashi,Ei
AU  - Mikami,Shigeru
AU  - Moriya,Akio
AU  - Okubo,Hironao
AU  - Tani,Joji
AU  - Tsubota,Akihito
AU  - Tanaka,Yasuhito
AU  - Masaki,Tsutomu
AU  - Iwakiri,Katsuhiko
AU  - Kumada,Takashi
TI  - Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
SN  - 1435-5922
PY  - 2019///0808
KW  - Aged
KW  - Aged, 80 and over
KW  - Amides
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Benzofurans
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Imidazoles
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Quinoxalines
KW  - Retrospective Studies
KW  - Sulfonamides
KW  - Sustained Virologic Response
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00535-018-1473-z
ER  -